Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EMA’s CHMP Recommends Approval of Merck’s KEYTRUDA® for the Treatment of Patients with Relapsed or R

americanpharmaceuticalreviewMarch 27, 2017

Tag: Keytruda , EMA

PharmaSources Customer Service